Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is one of the most malignant tumors. Immune checkpoint inhibitors (ICIs)-based therapy has recently been demonstrated to greatly ameliorate survival outcomes in advanced HCC. The objective of this research was to evaluate clinical outcomes of ICIs-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Huimin, Lei, Qing, Yan, Xin, Lai, Yunfeng, Ung, Carolina Oi Lam, Hu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818755/
https://www.ncbi.nlm.nih.gov/pubmed/36612256
http://dx.doi.org/10.3390/cancers15010260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818755/
https://www.ncbi.nlm.nih.gov/pubmed/36612256
http://dx.doi.org/10.3390/cancers15010260

Ejemplares similares